Please provide your email address to receive an email when new articles are posted on . Rituximab- and cyclophosphamide-based remission induction for ANCA-associated vasculitis demonstrate similar ...

Reports on heart failure mortality during the past several years show that it’s on the rise more recently compared to declines, but a research letter released Wednesday in JAMA Cardiology blames the ...

Please provide your email address to receive an email when new articles are posted on . Patients with kidney disease and eGFR of at least 45 mL/min/1.73 m 2 with the lowest socioeconomic status had ...

Both semaglutide and tirzepatide were shown to “significantly reduce” the risk of hospitalization and all-cause mortality for heart failure patients, according to a study published Aug. 31 in JAMA.

What happens after a first-time hospitalization for heart failure? While there are guidelines on optimal treatment of patients with heart failure, researchers at Baylor College of Medicine have found ...

Study findings indicate that proteinuria reduction is clinically meaningful. Proteinuria treatment delays kidney failure and prolongs survival in patients with IgA nephropathy (IgAN), investigators ...

The systemic immune-inflammation index (SII) was found to be a potential predictor of the prognosis of patients with chronic obstructive pulmonary disease (COPD). High systemic immune-inflammation ...

Frailty after kidney transplantation is a harbinger for death and other major adverse outcomes in hospitalized patients. The hospital frailty risk score (HFRS) predicts graft failure, severe infection ...

Living a sedentary lifestyle can harm your overall health, and sitting too much each day can particularly be harmful to your heart. A new study suggests that sitting for 10.6 hours or more a day is ...